PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest

References

• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501 - 12; http://dx.doi.org/10.1101/gad.13.12.1501; PMID: 10385618
   PubMed Web of Science ®Google Scholar
• Hengst L, Reed SI. Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol 1998; 227:25 - 41; http://dx.doi.org/10.1007/978-3-642-71941-7_2; PMID: 9479824
   PubMed Web of Science ®Google Scholar
• Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995; 308:697 - 711; PMID: 8948422
   PubMed Web of Science ®Google Scholar
• Nigg EA. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 1995; 17:471 - 80; http://dx.doi.org/10.1002/bies.950170603; PMID: 7575488
   PubMed Web of Science ®Google Scholar
• Alessandrini A, Chiaur DS, Pagano M. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 1997; 11:342 - 5; http://dx.doi.org/10.1038/sj.leu.2400581; PMID: 9067571
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59 - 66; http://dx.doi.org/10.1016/0092-8674(94)90572-X; PMID: 8033212
   PubMed Web of Science ®Google Scholar
• Ekholm SV, Reed SI. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000; 12:676 - 84; http://dx.doi.org/10.1016/S0955-0674(00)00151-4; PMID: 11063931
   PubMed Web of Science ®Google Scholar
• Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183:10 - 7; http://dx.doi.org/10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; PMID: 10699961
   PubMed Web of Science ®Google Scholar
• Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269:682 - 5; http://dx.doi.org/10.1126/science.7624798; PMID: 7624798
   PubMed Web of Science ®Google Scholar
• Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372:570 - 3; http://dx.doi.org/10.1038/372570a0; PMID: 7990932
   PubMed Web of Science ®Google Scholar
• Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996; 16:4327 - 36; PMID: 8754833
   PubMed Web of Science ®Google Scholar
• Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008; 14:159 - 69; http://dx.doi.org/10.1016/j.devcel.2008.01.013; PMID: 18267085
   PubMed Web of Science ®Google Scholar
• Sicinski P, Zacharek S, Kim C. Duality of p27Kip1 function in tumorigenesis. Genes Dev 2007; 21:1703 - 6; http://dx.doi.org/10.1101/gad.1583207; PMID: 17639075
   PubMed Web of Science ®Google Scholar
• Borriello A, Cucciolla V, Oliva A, Zappia V, Della Ragione F. p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle 2007; 6:1053 - 61; http://dx.doi.org/10.4161/cc.6.9.4142; PMID: 17426451
   PubMed Web of Science ®Google Scholar
• Müller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, et al. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 1997; 15:2561 - 76; http://dx.doi.org/10.1038/sj.onc.1201440; PMID: 9399644
   PubMed Web of Science ®Google Scholar
• Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997; 11:1464 - 78; http://dx.doi.org/10.1101/gad.11.11.1464; PMID: 9192873
   PubMed Web of Science ®Google Scholar
• Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 1997; 16:5334 - 44; http://dx.doi.org/10.1093/emboj/16.17.5334; PMID: 9311993
   PubMed Web of Science ®Google Scholar
• Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999; 13:1181 - 9; http://dx.doi.org/10.1101/gad.13.9.1181; PMID: 10323868
   PubMed Web of Science ®Google Scholar
• Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193 - 9; http://dx.doi.org/10.1038/12013; PMID: 10559916
   PubMed Web of Science ®Google Scholar
• Sutterlüty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Müller U, et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1:207 - 14; http://dx.doi.org/10.1038/12027; PMID: 10559918
   PubMed Web of Science ®Google Scholar
• Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9:661 - 4; http://dx.doi.org/10.1016/S0960-9822(99)80290-5; PMID: 10375532
   PubMed Web of Science ®Google Scholar
• Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19:2069 - 81; http://dx.doi.org/10.1093/emboj/19.9.2069; PMID: 10790373
   PubMed Web of Science ®Google Scholar
• Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, et al. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001; 3:321 - 4; http://dx.doi.org/10.1038/35060126; PMID: 11231585
   PubMed Web of Science ®Google Scholar
• Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, et al. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 2001; 7:639 - 50; http://dx.doi.org/10.1016/S1097-2765(01)00210-6; PMID: 11463388
   PubMed Web of Science ®Google Scholar
• Fujita N, Sato S, Katayama K, Tsuruo T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2002; 277:28706 - 13; http://dx.doi.org/10.1074/jbc.M203668200; PMID: 12042314
   PubMed Web of Science ®Google Scholar
• Motti ML, De Marco C, Califano D, Fusco A, Viglietto G. Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer. Cell Cycle 2004; 3:1074 - 80; http://dx.doi.org/10.4161/cc.3.8.1073; PMID: 15280662
   PubMed Web of Science ®Google Scholar
• Fujita N, Sato S, Tsuruo T. Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2003; 278:49254 - 60; http://dx.doi.org/10.1074/jbc.M306614200; PMID: 14504289
   PubMed Web of Science ®Google Scholar
• Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9:218 - 24; http://dx.doi.org/10.1038/ncb1537; PMID: 17237771
   PubMed Web of Science ®Google Scholar
• Kossatz U, Vervoorts J, Nickeleit I, Sundberg HA, Arthur JS, Manns MP, et al. C-terminal phosphorylation controls the stability and function of p27kip1. EMBO J 2006; 25:5159 - 70; http://dx.doi.org/10.1038/sj.emboj.7601388; PMID: 17053782
   PubMed Web of Science ®Google Scholar
• Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18:862 - 76; http://dx.doi.org/10.1101/gad.1185504; PMID: 15078817
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233:305 - 12; http://dx.doi.org/10.1126/science.3014651; PMID: 3014651
   PubMed Web of Science ®Google Scholar
• Lévesque JT, Sirard MA. Effects of different kinases and phosphatases on nuclear and cytoplasmic maturation of bovine oocytes. Mol Reprod Dev 1995; 42:114 - 21; http://dx.doi.org/10.1002/mrd.1080420115; PMID: 8562045
   PubMed Web of Science ®Google Scholar
• Saxon ML, Zhao X, Black JD. Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ. J Cell Biol 1994; 126:747 - 63; http://dx.doi.org/10.1083/jcb.126.3.747; PMID: 8045938
   PubMed Web of Science ®Google Scholar
• Spitaler M, Cantrell DA. Protein kinase C and beyond. Nat Immunol 2004; 5:785 - 90; http://dx.doi.org/10.1038/ni1097; PMID: 15282562
   PubMed Web of Science ®Google Scholar
• Shirai Y, Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem 2002; 132:663 - 8; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003271; PMID: 12417013
   PubMed Web of Science ®Google Scholar
• Zhou FF, Xue Y, Chen GL, Yao X. GPS: a novel group-based phosphorylation predicting and scoring method. Biochem Biophys Res Commun 2004; 325:1443 - 8; http://dx.doi.org/10.1016/j.bbrc.2004.11.001; PMID: 15555589
   PubMed Web of Science ®Google Scholar
• Ballester R, Rosen OM. Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate. J Biol Chem 1985; 260:15194 - 9; PMID: 3905792
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9:484 - 96; PMID: 7737456
   PubMed Web of Science ®Google Scholar
• Coats S, Flanagan WM, Nourse J, Roberts JM. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272:877 - 80; http://dx.doi.org/10.1126/science.272.5263.877; PMID: 8629023
   PubMed Web of Science ®Google Scholar
• Rivard N, L’Allemain G, Bartek J, Pouysségur J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J Biol Chem 1996; 271:18337 - 41; http://dx.doi.org/10.1074/jbc.271.31.18337; PMID: 8702474
   PubMed Web of Science ®Google Scholar
• Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 2006; 20:47 - 64; http://dx.doi.org/10.1101/gad.1384406; PMID: 16391232
   PubMed Web of Science ®Google Scholar
• Deng X, Mercer SE, Shah S, Ewton DZ, Friedman E. The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase. J Biol Chem 2004; 279:22498 - 504; http://dx.doi.org/10.1074/jbc.M400479200; PMID: 15010468
   PubMed Web of Science ®Google Scholar
• Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, et al. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J 2002; 21:3390 - 401; http://dx.doi.org/10.1093/emboj/cdf343; PMID: 12093740
   PubMed Web of Science ®Google Scholar
• Batlle E, Verdú J, Domínguez D, del Mont Llosas M, Díaz V, Loukili N, et al. Protein kinase C-alpha activity inversely modulates invasion and growth of intestinal cells. J Biol Chem 1998; 273:15091 - 8; http://dx.doi.org/10.1074/jbc.273.24.15091; PMID: 9614119
   PubMed Web of Science ®Google Scholar
• Abraham C, Scaglione-Sewell B, Skarosi SF, Qin W, Bissonnette M, Brasitus TA. Protein kinase C alpha modulates growth and differentiation in Caco-2 cells. Gastroenterology 1998; 114:503 - 9; http://dx.doi.org/10.1016/S0016-5085(98)70533-5; PMID: 9496940
   PubMed Web of Science ®Google Scholar
• Kharait S, Dhir R, Lauffenburger D, Wells A. Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun 2006; 343:848 - 56; http://dx.doi.org/10.1016/j.bbrc.2006.03.044; PMID: 16564022
   PubMed Web of Science ®Google Scholar
• Haughian JM, Reno EM, Thorne AM, Bradford AP. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. Int J Cancer 2009; 125:2556 - 64; http://dx.doi.org/10.1002/ijc.24633; PMID: 19672862
   PubMed Web of Science ®Google Scholar
• Margolis EJ, Choi JC, Shu WP, Liu BC. Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer. Cancer Lett 1996; 100:163 - 8; http://dx.doi.org/10.1016/0304-3835(95)04096-X; PMID: 8620437
   PubMed Web of Science ®Google Scholar
• Wu TT, Hsieh YH, Wu CC, Hsieh YS, Huang CY, Liu JY. Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis. Clin Chim Acta 2007; 382:54 - 8; http://dx.doi.org/10.1016/j.cca.2007.03.018; PMID: 17459358
   PubMed Web of Science ®Google Scholar
• Weinstein IB. Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ Health Perspect 1991; 93:175 - 9; http://dx.doi.org/10.1289/ehp.9193175; PMID: 1773790
   PubMed Web of Science ®Google Scholar
• McGarrity TJ, Peiffer LP. Protein kinase C activity as a potential marker for colorectal neoplasia. Dig Dis Sci 1994; 39:458 - 63; http://dx.doi.org/10.1007/BF02088328; PMID: 8131680
   PubMed Web of Science ®Google Scholar
• Kahl-Rainer P, Karner-Hanusch J, Weiss W, Marian B. Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon. Carcinogenesis 1994; 15:779 - 82; http://dx.doi.org/10.1093/carcin/15.4.779; PMID: 8149496
   PubMed Web of Science ®Google Scholar
• Kahl-Rainer P, Sedivy R, Marian B. Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control. Gastroenterology 1996; 110:1753 - 9; http://dx.doi.org/10.1053/gast.1996.v110.pm8964400; PMID: 8964400
   PubMed Web of Science ®Google Scholar
• Brasitus TA, Bissonnette M. PKC isoforms: villains in colon cancer?. Gastroenterology 1998; 115:225 - 7; http://dx.doi.org/10.1016/S0016-5085(98)70387-7; PMID: 9649481
   PubMed Web of Science ®Google Scholar
• Verstovsek G, Byrd A, Frey MR, Petrelli NJ, Black JD. Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. Gastroenterology 1998; 115:75 - 85; http://dx.doi.org/10.1016/S0016-5085(98)70367-1; PMID: 9649461
   PubMed Web of Science ®Google Scholar
• Black JD. Protein kinase C isozymes in colon carcinogenesis: guilt by omission. Gastroenterology 2001; 120:1868 - 72; http://dx.doi.org/10.1053/gast.2001.25287; PMID: 11375968
   PubMed Web of Science ®Google Scholar
• Frey MR, Saxon ML, Zhao X, Rollins A, Evans SS, Black JD. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem 1997; 272:9424 - 35; http://dx.doi.org/10.1074/jbc.272.14.9424; PMID: 9083081
   PubMed Web of Science ®Google Scholar
• Frey MR, Clark JA, Leontieva O, Uronis JM, Black AR, Black JD. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol 2000; 151:763 - 78; http://dx.doi.org/10.1083/jcb.151.4.763; PMID: 11076962
   PubMed Web of Science ®Google Scholar
• Clark JA, Black AR, Leontieva OV, Frey MR, Pysz MA, Kunneva L, et al. Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells. J Biol Chem 2004; 279:9233 - 47; http://dx.doi.org/10.1074/jbc.M312268200; PMID: 14670956
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S, et al. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 1997; 272:13816 - 22; http://dx.doi.org/10.1074/jbc.272.21.13816; PMID: 9153238
   PubMed Web of Science ®Google Scholar
• Toyoda M, Gotoh N, Handa H, Shibuya M. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells. Biochem Biophys Res Commun 1998; 250:430 - 5; http://dx.doi.org/10.1006/bbrc.1998.9332; PMID: 9753647
   PubMed Web of Science ®Google Scholar
• Ashton AW, Watanabe G, Albanese C, Harrington EO, Ware JA, Pestell RG. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). J Biol Chem 1999; 274:20805 - 11; http://dx.doi.org/10.1074/jbc.274.30.20805; PMID: 10409620
   PubMed Web of Science ®Google Scholar
• Shanmugam M, Krett NL, Maizels ET, Murad FM, Rosen ST, Hunzicker-Dunn M. A role for protein kinase C delta in the differential sensitivity of MCF-7 and MDA-MB 231 human breast cancer cells to phorbol ester-induced growth arrest and p21(WAFI/CIP1) induction. Cancer Lett 2001; 172:43 - 53; http://dx.doi.org/10.1016/S0304-3835(01)00602-4; PMID: 11595128
   PubMed Web of Science ®Google Scholar
• Page K, Li J, Corbit KC, Rumilla KM, Soh JW, Weinstein IB, et al. Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta. Am J Respir Cell Mol Biol 2002; 27:204 - 13; PMID: 12151312
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, Kazanietz MG. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 2005; 280:33926 - 34; http://dx.doi.org/10.1074/jbc.M505748200; PMID: 16055435
   PubMed Web of Science ®Google Scholar
• Pysz MA, Leontieva OV, Bateman NW, Uronis JM, Curry KJ, Threadgill DW, et al. PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. Exp Cell Res 2009; 315:1415 - 28; http://dx.doi.org/10.1016/j.yexcr.2009.02.002; PMID: 19232344
   PubMed Web of Science ®Google Scholar
• Afrasiabi E, Ahlgren J, Bergelin N, Törnquist K. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta. Mol Cell Endocrinol 2008; 292:26 - 35; http://dx.doi.org/10.1016/j.mce.2008.04.018; PMID: 18541361
   PubMed Web of Science ®Google Scholar
• Baldassarre G, Barone MV, Belletti B, Sandomenico C, Bruni P, Spiezia S, et al. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 1999; 18:6241 - 51; http://dx.doi.org/10.1038/sj.onc.1203031; PMID: 10597222
   PubMed Web of Science ®Google Scholar